Barely Significant
← all excerpts

Identification of patients with advanced pancreatic cancer who might benefit from third-line chemotherapy.

World J Gastrointest Oncol · 2025 · PMC11756000 · PMID 39958540

Europe PMCDOI
1
hedged sentence
0.0770
closest p · 1.5× alpha
0.0770
boldest claim

The sentences

borderline significantP = 0.077so close (0.05 < p ≤ 0.1)
Although further studies are necessary, there is a possibility that longer second-line chemotherapy might reflect better PS, as we found a borderline significant ( P = 0.077, data not shown) association between good PS and second-line chemotherapy of ≥ 19 weeks.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.